nach oben

Reactions Weekly

Erschienen in:

01.07.2019 | Case report

Cefepime/piperacillin/tazobactam

Acute kidney injury: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In a single-centre retrospective cohort observational study conducted in Japan, 163 patients were recruited from 1 January 2012 to 30 July 2016 in the piperacillin/tazobactam group and 103 patients from 1 January 2009 to 30 July 2016 in the cefepime group. In the study, two patients [ages and sexes not stated] were described, who developed acute kidney injury (AKI) during treatment with piperacillin/tazobactam (1 patient) and cefepime (1 patient). …

Kadomura S, et al. Higher incidence of acute kidney injury in patients treated with piperacillin/tazobactam than in patients treated with cefepime: A single-center retrospective cohort study. Journal of Pharmaceutical Health Care and Sciences 5: 13, No. 1, 12 Jun 2019. Available from: URL: http://doi.org/10.1186/s40780-019-0142-6 - Japan

Titel: Cefepime/piperacillin/tazobactam
Acute kidney injury: 2 case reports
Publikationsdatum: 01.07.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-64474-2

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Cefepime/piperacillin/tazobactam

Acute kidney injury: 2 case reports

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Leflunomide

Radix glycyrrhizae/rheum

Raltegravir

Zonisamide

Pazopanib

Levodopa/carbidopa abuse